The EU drug regulator noted that the vaccine, known as Imvanex in Europe but sold as Jynneos in the U.S., is already cleared for use against monkeypox by American regulators.

The EMA, which so far has approved four COVID-19 vaccines, added that no application seeking marketing authorization for the Sinovac vaccine has been submitted yet.